Hugo_Symbol	Entrez_Gene_Id	Center	NCBI_Build	Chromosome	Start_position	End_position	Strand	Variant_Classification	Variant_Type	Reference_Allele	Tumor_Seq_Allele1	Tumor_Seq_Allele2	dbSNP_RS	dbSNP_Val_Status	Tumor_Sample_Barcode	Matched_Norm_Sample_Barcode	Match_Norm_Seq_Allele1	Match_Norm_Seq_Allele2	Tumor_Validation_Allele1	Tumor_Validation_Allele2	Match_Norm_Validation_Allele1	Match_Norm_Validation_Allele2	Verification_Status	Validation_Status	Mutation_Status	Sequencing_Phase	Sequence_Source	Validation_Method	Score	BAM_file	Sequencer	Tumor_Sample_UUID	Matched_Norm_Sample_UUID	Genome_Change	Annotation_Transcript	Transcript_Strand	Transcript_Exon	Transcript_Position	cDNA_Change	Codon_Change	Protein_Change	Other_Transcripts	Refseq_mRNA_Id	Refseq_prot_Id	SwissProt_acc_Id	SwissProt_entry_Id	Description	UniProt_AApos	UniProt_Region	UniProt_Site	UniProt_Natural_Variations	UniProt_Experimental_Info	GO_Biological_Process	GO_Cellular_Component	GO_Molecular_Function	COSMIC_overlapping_mutations	COSMIC_fusion_genes	COSMIC_tissue_types_affected	COSMIC_total_alterations_in_gene	Tumorscape_Amplification_Peaks	Tumorscape_Deletion_Peaks	TCGAscape_Amplification_Peaks	TCGAscape_Deletion_Peaks	DrugBank	ref_context	gc_content	CCLE_ONCOMAP_overlapping_mutations	CCLE_ONCOMAP_total_mutations_in_gene	CGC_Mutation_Type	CGC_Translocation_Partner	CGC_Tumor_Types_Somatic	CGC_Tumor_Types_Germline	CGC_Other_Diseases	DNARepairGenes_Role	FamilialCancerDatabase_Syndromes	MUTSIG_Published_Results	OREGANNO_ID	OREGANNO_Values	i_1000Genome_AA	i_1000Genome_AC	i_1000Genome_AF	i_1000Genome_AFR_AF	i_1000Genome_AMR_AF	i_1000Genome_AN	i_1000Genome_ASN_AF	i_1000Genome_AVGPOST	i_1000Genome_CIEND	i_1000Genome_CIPOS	i_1000Genome_END	i_1000Genome_ERATE	i_1000Genome_EUR_AF	i_1000Genome_HOMLEN	i_1000Genome_HOMSEQ	i_1000Genome_LDAF	i_1000Genome_RSQ	i_1000Genome_SNPSOURCE	i_1000Genome_SVLEN	i_1000Genome_SVTYPE	i_1000Genome_THETA	i_1000Genome_VT	i_ACHILLES_Lineage_Results_Top_Genes	i_CGC_CancerGermlineMut	i_CGC_CancerMolecularGenetics	i_CGC_CancerSomaticMut	i_CGC_CancerSyndrome	i_CGC_Chr	i_CGC_ChrBand	i_CGC_GeneID	i_CGC_Name	i_CGC_OtherGermlineMut	i_CGC_TissueType	i_COSMIC_n_overlapping_mutations	i_COSMIC_overlapping_mutation_descriptions	i_COSMIC_overlapping_primary_sites	i_ClinVar_ASSEMBLY	i_ClinVar_HGMD_ID	i_ClinVar_SYM	i_ClinVar_TYPE	i_ClinVar_rs	i_ESP_AA	i_ESP_AAC	i_ESP_AA_AC	i_ESP_AA_AGE	i_ESP_AA_GTC	i_ESP_AvgAAsampleReadDepth	i_ESP_AvgEAsampleReadDepth	i_ESP_AvgSampleReadDepth	i_ESP_CA	i_ESP_CDP	i_ESP_CG	i_ESP_CP	i_ESP_Chromosome	i_ESP_DBSNP	i_ESP_DP	i_ESP_EA_AC	i_ESP_EA_AGE	i_ESP_EA_GTC	i_ESP_EXOME_CHIP	i_ESP_FG	i_ESP_GL	i_ESP_GM	i_ESP_GS	i_ESP_GTC	i_ESP_GTS	i_ESP_GWAS_PUBMED	i_ESP_MAF	i_ESP_PH	i_ESP_PP	i_ESP_Position	i_ESP_TAC	i_ESP_TotalAAsamplesCovered	i_ESP_TotalEAsamplesCovered	i_ESP_TotalSamplesCovered	i_Ensembl_so_accession	i_Ensembl_so_term	i_Familial_Cancer_Genes_Reference	i_Familial_Cancer_Genes_Synonym	i_HGNC_EnsemblGeneID	i_HGNC_HGNCID	i_HGNC_RefSeqIDs	i_HGNC_Status	i_HGNC_UCSCIDsuppliedbyUCSC	i_ORegAnno_bin	i_UniProt_alt_uniprot_accessions	i_annotation_transcript	i_build	i_ccds_id	i_dbNSFP_1000Gp1_AC	i_dbNSFP_1000Gp1_AF	i_dbNSFP_1000Gp1_AFR_AC	i_dbNSFP_1000Gp1_AFR_AF	i_dbNSFP_1000Gp1_AMR_AC	i_dbNSFP_1000Gp1_AMR_AF	i_dbNSFP_1000Gp1_ASN_AC	i_dbNSFP_1000Gp1_ASN_AF	i_dbNSFP_1000Gp1_EUR_AC	i_dbNSFP_1000Gp1_EUR_AF	i_dbNSFP_Ancestral_allele	i_dbNSFP_CADD_phred	i_dbNSFP_CADD_raw	i_dbNSFP_CADD_raw_rankscore	i_dbNSFP_ESP6500_AA_AF	i_dbNSFP_ESP6500_EA_AF	i_dbNSFP_Ensembl_geneid	i_dbNSFP_Ensembl_transcriptid	i_dbNSFP_FATHMM_pred	i_dbNSFP_FATHMM_rankscore	i_dbNSFP_FATHMM_score	i_dbNSFP_GERP_NR	i_dbNSFP_GERP_RS	i_dbNSFP_GERP_RS_rankscore	i_dbNSFP_Interpro_domain	i_dbNSFP_LRT_Omega	i_dbNSFP_LRT_converted_rankscore	i_dbNSFP_LRT_pred	i_dbNSFP_LRT_score	i_dbNSFP_LR_pred	i_dbNSFP_LR_rankscore	i_dbNSFP_LR_score	i_dbNSFP_MutationAssessor_pred	i_dbNSFP_MutationAssessor_rankscore	i_dbNSFP_MutationAssessor_score	i_dbNSFP_MutationTaster_converted_rankscore	i_dbNSFP_MutationTaster_pred	i_dbNSFP_MutationTaster_score	i_dbNSFP_Polyphen2_HDIV_pred	i_dbNSFP_Polyphen2_HDIV_rankscore	i_dbNSFP_Polyphen2_HDIV_score	i_dbNSFP_Polyphen2_HVAR_pred	i_dbNSFP_Polyphen2_HVAR_rankscore	i_dbNSFP_Polyphen2_HVAR_score	i_dbNSFP_RadialSVM_pred	i_dbNSFP_RadialSVM_rankscore	i_dbNSFP_RadialSVM_score	i_dbNSFP_Reliability_index	i_dbNSFP_SIFT_converted_rankscore	i_dbNSFP_SIFT_pred	i_dbNSFP_SIFT_score	i_dbNSFP_SLR_test_statistic	i_dbNSFP_SiPhy_29way_logOdds	i_dbNSFP_SiPhy_29way_logOdds_rankscore	i_dbNSFP_SiPhy_29way_pi	i_dbNSFP_UniSNP_ids	i_dbNSFP_Uniprot_aapos	i_dbNSFP_Uniprot_acc	i_dbNSFP_Uniprot_id	i_dbNSFP_aaalt	i_dbNSFP_aapos	i_dbNSFP_aapos_FATHMM	i_dbNSFP_aapos_SIFT	i_dbNSFP_aaref	i_dbNSFP_cds_strand	i_dbNSFP_codonpos	i_dbNSFP_folddegenerate	i_dbNSFP_genename	i_dbNSFP_hg18_pos1coor	i_dbNSFP_phastCons100way_vertebrate	i_dbNSFP_phastCons100way_vertebrate_rankscore	i_dbNSFP_phastCons46way_placental	i_dbNSFP_phastCons46way_placental_rankscore	i_dbNSFP_phastCons46way_primate	i_dbNSFP_phastCons46way_primate_rankscore	i_dbNSFP_phyloP100way_vertebrate	i_dbNSFP_phyloP100way_vertebrate_rankscore	i_dbNSFP_phyloP46way_placental	i_dbNSFP_phyloP46way_placental_rankscore	i_dbNSFP_phyloP46way_primate	i_dbNSFP_phyloP46way_primate_rankscore	i_dbNSFP_refcodon	i_gencode_transcript_name	i_gencode_transcript_status	i_gencode_transcript_tags	i_gencode_transcript_type	i_gene_id	i_gene_type	i_havana_transcript	i_init_t_lod	i_judgement	i_secondary_variant_classification	i_strand	i_t_lod_fstar	i_tumor_f	t_alt_count	t_ref_count	validation_alt_allele	validation_method	validation_status	validation_tumor_sample	validation_judgement_rna	validation_power_rna	validation_tumor_alt_count_rna	validation_tumor_ref_count_rna	validation_normal_alt_count_rna	validation_normal_ref_count_rna	discovery_tumor_alt_count_rna	discovery_tumor_ref_count_rna	discovery_normal_alt_count_rna	discovery_normal_ref_count_rna	min_val_count_rna	validation_judgement_targeted	validation_power_targeted	validation_tumor_alt_count_targeted	validation_tumor_ref_count_targeted	validation_normal_alt_count_targeted	validation_normal_ref_count_targeted	discovery_tumor_alt_count_targeted	discovery_tumor_ref_count_targeted	discovery_normal_alt_count_targeted	discovery_normal_ref_count_targeted	min_val_count_targeted	validation_status_consensus
STAG1	10274	broad.mit.edu	37	3	136162169	136162169	+	Missense_Mutation	SNP	C	C	G			THCA-TCGA-EL-A3GR-Tumor-SM-2HRLM	THCA-TCGA-EL-A3GR-Normal-SM-2HRLR	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	THCA-TCGA-EL-A3GR-Tumor-SM-2HRLM	THCA-TCGA-EL-A3GR-Normal-SM-2HRLR	g.chr3:136162169C>G	ENST00000383202.2	-	15	1762	c.1506G>C	c.(1504-1506)atG>atC	p.M502I	STAG1_ENST00000536929.1_Missense_Mutation_p.M86I|STAG1_ENST00000434713.2_Missense_Mutation_p.M276I|STAG1_ENST00000236698.5_Missense_Mutation_p.M502I	NM_005862.2	NP_005853.2	Q8WVM7	STAG1_HUMAN	stromal antigen 1	502		NA			cell division|chromosome segregation|mitotic metaphase/anaphase transition|mitotic prometaphase	cell junction|chromatin|chromosome, centromeric region|nucleoplasm	protein binding			NS(2)|breast(4)|central_nervous_system(1)|endometrium(5)|haematopoietic_and_lymphoid_tissue(1)|kidney(5)|large_intestine(16)|lung(16)|ovary(2)|prostate(2)|skin(1)|upper_aerodigestive_tract(1)|urinary_tract(2)	58						GCAACTCTGTCATACATTCCC	0.358		NA				NA		NA			NA	NA		NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA			NA			NA	NA		NA				0								NA	NA	NA	NA	NA	140	133	135	NA	NA	NA	NA	3	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	136162169	NA	2203	4300	6503	SO:0001583	missense			ENSG00000118007	HGNC:11354	NM_005862	Approved	uc003era.1	NA	O00539	ENST00000383202.2	37	CCDS3090.1	.|.	.|.	.|.	.|.	.|.	.|.	.|.	.|.	.|.	.|.	C|C	24.1|24.1	4.488922|4.488922	0.84962|0.84962	.|.	.|.	ENSG00000118007|ENSG00000118007	ENST00000383202;ENST00000236698;ENST00000434713;ENST00000536929|ENST00000492318	T;T;T;T|.	0.38077|.	1.7;1.72;1.83;1.16|.	5.83|5.83	5.83|5.83	0.93111|0.93111	Armadillo-type fold (1);|.	0.000000|.	0.85682|.	D|.	0.000000|.	D|.	0.82866|.	0.5130|.	M|M	0.83312|0.83312	2.635|2.635	0.80722|0.80722	D|D	1|1	P;B;P|.	0.48089|.	0.905;0.382;0.843|.	P;B;P|.	0.52598|.	0.703;0.146;0.613|.	T|.	0.82916|.	-0.0220|.	10|.	0.30078|.	T|.	0.28|.	.|.	20.1133|20.1133	0.97917|0.97917	0.0:1.0:0.0:0.0|0.0:1.0:0.0:0.0	.|.	519;502;502|.	Q4LE48;Q6P275;Q8WVM7|.	.;.;STAG1_HUMAN|.	I|S	502;502;276;86|113	ENSP00000372689:M502I;ENSP00000236698:M502I;ENSP00000404396:M276I;ENSP00000445787:M86I|.	ENSP00000236698:M502I|.	M|X	-|-	3|2	0|2	STAG1|STAG1	137644859|137644859	1.000000|1.000000	0.71417|0.71417	1.000000|1.000000	0.80357|0.80357	0.998000|0.998000	0.95712|0.95712	7.818000|7.818000	0.86416|0.86416	2.762000|2.762000	0.94881|0.94881	0.591000|0.591000	0.81541|0.81541	ATG|TGA	STAG1-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000357366.1	-0.562815	KEEP		-	19.065679	0.068627	7	95	---	---	---	---	1	0.8865662	5	51	0	128	8	110	0	128	2	0	0	0	0	0	0	8	110	0	128	2	TP
CLCN3	0	broad.mit.edu	37	4	170641066	170641066	+	Missense_Mutation	SNP	T	T	C			THCA-TCGA-EL-A3GR-Tumor-SM-2HRLM	THCA-TCGA-EL-A3GR-Normal-SM-2HRLR	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	THCA-TCGA-EL-A3GR-Tumor-SM-2HRLM	THCA-TCGA-EL-A3GR-Normal-SM-2HRLR	g.chr4:170641066T>C	ENST00000513761.1	+	13	2934	c.2375T>C	c.(2374-2376)cTt>cCt	p.L792P	CLCN3_ENST00000504131.2_Missense_Mutation_p.L775P|CLCN3_ENST00000360642.3_Missense_Mutation_p.L765P|CLCN3_ENST00000347613.4_Silent_p.P817P	NM_001829.3	NP_001820.2	P51790	CLCN3_HUMAN	chloride channel, voltage-sensitive 3	792	CBS 2.	NA			endosomal lumen acidification	cell surface|early endosome membrane|Golgi membrane|integral to membrane|late endosome membrane|transport vesicle membrane	antiporter activity|ATP binding|PDZ domain binding|protein heterodimerization activity|protein homodimerization activity|voltage-gated chloride channel activity			breast(5)|endometrium(3)|large_intestine(8)|lung(8)|ovary(1)|skin(1)|stomach(2)|upper_aerodigestive_tract(1)	29		Prostate(90;0.00601)|Renal(120;0.0183)		GBM - Glioblastoma multiforme(119;0.0233)|LUSC - Lung squamous cell carcinoma(193;0.131)		AGGCGCCTCCTTGGCATTATA	0.398		NA				NA		NA			NA	NA		NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA			NA			NA	NA		NA				0								NA	NA	NA	NA	NA	42	45	44	NA	NA	NA	NA	4	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	170641066	NA	2196	4299	6495	SO:0001583	missense			ENSG00000109572	HGNC:2021		Approved	uc003ish.3	NA	D3DP34|O14918|Q86Z21	ENST00000513761.1	37	CCDS34101.1	.	.	.	.	.	.	.	.	.	.	T	18.99	3.740737	0.69304	.	.	ENSG00000109572	ENST00000513761;ENST00000360642;ENST00000504131	D;D;D	0.94537	-3.45;-3.45;-3.45	5.52	5.52	0.82312	Cystathionine beta-synthase, core (3);	.	.	.	.	D	0.97087	0.9048	.	.	.	0.80722	D	1	D;D;D	0.89917	0.999;1.0;1.0	D;D;D	0.79784	0.988;0.993;0.991	D	0.97250	0.9897	7	.	.	.	-6.6465	15.6299	0.76899	0.0:0.0:0.0:1.0	.	765;775;792	B7Z932;B9EGJ9;P51790	.;.;CLCN3_HUMAN	P	792;765;775	ENSP00000424603:L792P;ENSP00000353857:L765P;ENSP00000424540:L775P	.	L	+	2	0	CLCN3	170877641	1.000000	0.71417	1.000000	0.80357	0.997000	0.91878	8.036000	0.88901	2.086000	0.62901	0.533000	0.62120	CTT	CLCN3-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000363210.2	2.422934	KEEP		+	14.066437	0.078125	5	59	---	---	---	---	1	0.9660437	6	57	0	61	7	69	0	61	2	0	0	0	0	0	0	7	69	0	61	2	TP
NUDT12	83594	broad.mit.edu	37	5	102895751	102895751	+	Missense_Mutation	SNP	C	C	G			THCA-TCGA-EL-A3GR-Tumor-SM-2HRLM	THCA-TCGA-EL-A3GR-Normal-SM-2HRLR	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	THCA-TCGA-EL-A3GR-Tumor-SM-2HRLM	THCA-TCGA-EL-A3GR-Normal-SM-2HRLR	g.chr5:102895751C>G	ENST00000230792.2	-	2	295	c.199G>C	c.(199-201)Gag>Cag	p.E67Q	NUDT12_ENST00000507423.1_Intron	NM_031438.2	NP_113626.1	Q9BQG2	NUD12_HUMAN	nudix (nucleoside diphosphate linked moiety X)-type motif 12	67		NA				nucleus|peroxisome	metal ion binding|NAD+ diphosphatase activity			endometrium(1)|kidney(1)|large_intestine(2)|liver(1)|lung(6)|urinary_tract(1)	12		all_cancers(142;6.38e-08)|all_epithelial(76;1.99e-10)|Prostate(80;0.0138)|Lung NSC(167;0.0212)|Colorectal(57;0.0247)|all_lung(232;0.0283)|Ovarian(225;0.0423)		Epithelial(69;9.3e-13)|COAD - Colon adenocarcinoma(37;0.0221)		TACCCTTTCTCAAGCAGAAAT	0.363		NA				NA		NA			NA	NA		NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA			NA			NA	NA		NA				0								NA	NA	NA	NA	NA	108	103	104	NA	NA	NA	NA	5	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	102895751	NA	2202	4300	6502	SO:0001583	missense			ENSG00000112874	HGNC:18826	NM_031438	Approved	uc003koi.3	NA	B3KUW2|Q8TAL7	ENST00000230792.2	37	CCDS4096.1	.	.	.	.	.	.	.	.	.	.	C	14.91	2.676933	0.47886	.	.	ENSG00000112874	ENST00000230792	T	0.67345	-0.26	5.9	5.9	0.94986	Ankyrin repeat-containing domain (4);	0.278431	0.39210	N	0.001440	T	0.54062	0.1835	N	0.16368	0.405	0.80722	D	1	B	0.24920	0.114	B	0.26416	0.069	T	0.49753	-0.8906	10	0.38643	T	0.18	-4.2576	17.1924	0.86883	0.0:0.8744:0.1256:0.0	.	67	Q9BQG2	NUD12_HUMAN	Q	67	ENSP00000230792:E67Q	ENSP00000230792:E67Q	E	-	1	0	NUDT12	102923650	1.000000	0.71417	1.000000	0.80357	0.981000	0.71138	3.749000	0.55150	2.788000	0.95919	0.650000	0.86243	GAG	NUDT12-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000250650.1	154.708631	KEEP		-	158.551661	0.323741	45	94	---	---	---	---	1	0.9999999	26	32	0	161	53	114	0	161	2	0	0	0	0	0	0	53	114	0	161	2	TP
BRAF	673	broad.mit.edu	37	7	140453136	140453136	+	Missense_Mutation	SNP	A	A	T	rs121913377|rs121913227		THCA-TCGA-EL-A3GR-Tumor-SM-2HRLM	THCA-TCGA-EL-A3GR-Normal-SM-2HRLR	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Valid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	THCA-TCGA-EL-A3GR-Tumor-SM-2HRLM	THCA-TCGA-EL-A3GR-Normal-SM-2HRLR	g.chr7:140453136A>T	ENST00000288602.6	-	15	1859	c.1799T>A	c.(1798-1800)gTg>gAg	p.V600E		NM_004333.4	NP_004324.2	P15056	BRAF_HUMAN	v-raf murine sarcoma viral oncogene homolog B	600	Protein kinase.	NA	V -> D (in a melanoma cell line; requires 2 nucleotide substitutions).|V -> E (in sarcoma, colorectal adenocarcinoma, metastatic melanoma, ovarian serous carcinoma, pilocytic astrocytoma; somatic mutation; most common mutation; constitutive and elevated kinase activity; efficiently induces cell transformation; suppression of mutation in melanoma causes growth arrest and promotes apoptosis).		activation of MAPKK activity|anti-apoptosis|nerve growth factor receptor signaling pathway|organ morphogenesis|positive regulation of peptidyl-serine phosphorylation|small GTPase mediated signal transduction|synaptic transmission	cytosol|nucleus|plasma membrane	ATP binding|metal ion binding	p.V600E(15453)|p.V600K(252)|p.V600R(44)|p.V600D(16)|p.V600A(12)|p.V600_K601>E(12)|p.V600G(11)|p.T599_R603>I(2)|p.V600Q(2)|p.V600_S605>EK(1)|p.V600_S605>DV(1)|p.V600_S605>D(1)|p.T599_V600insDFGLAT(1)	SLC45A3/BRAF(2)|AGTRAP/BRAF(2)|FAM131B_ENST00000443739/BRAF(7)|AKAP9_ENST00000356239/BRAF(10)|KIAA1549/BRAF(703)|FCHSD1/BRAF(2)	NS(588)|adrenal_gland(3)|autonomic_ganglia(3)|biliary_tract(29)|bone(7)|breast(21)|central_nervous_system(99)|cervix(6)|endometrium(33)|eye(72)|gastrointestinal_tract_(site_indeterminate)(2)|genital_tract(4)|haematopoietic_and_lymphoid_tissue(436)|kidney(3)|large_intestine(6953)|liver(17)|lung(192)|oesophagus(4)|ovary(275)|pancreas(15)|pituitary(1)|prostate(25)|salivary_gland(1)|skin(6285)|small_intestine(12)|soft_tissue(40)|stomach(11)|testis(7)|thyroid(12220)|upper_aerodigestive_tract(13)|urinary_tract(3)	27380	Melanoma(164;0.00956)				Sorafenib(DB00398)	TCGAGATTTCACTGTAGCTAG	0.368	V600D(K029AX_SKIN)|V600D(WM115_SKIN)|V600D(WM2664_SKIN)|V600E(8505C_THYROID)|V600E(A101D_SKIN)|V600E(A2058_SKIN)|V600E(A375_SKIN)|V600E(A673_BONE)|V600E(AM38_CENTRAL_NERVOUS_SYSTEM)|V600E(BCPAP_THYROID)|V600E(BHT101_THYROID)|V600E(BT474_BREAST)|V600E(C32_SKIN)|V600E(CL34_LARGE_INTESTINE)|V600E(COLO205_LARGE_INTESTINE)|V600E(COLO679_SKIN)|V600E(COLO741_SKIN)|V600E(COLO783_SKIN)|V600E(COLO800_SKIN)|V600E(COLO818_SKIN)|V600E(COLO829_SKIN)|V600E(COLO849_SKIN)|V600E(DBTRG05MG_CENTRAL_NERVOUS_SYSTEM)|V600E(DU4475_BREAST)|V600E(ES2_OVARY)|V600E(G361_SKIN)|V600E(GCT_SOFT_TISSUE)|V600E(HS294T_SKIN)|V600E(HS695T_SKIN)|V600E(HS939T_SKIN)|V600E(IGR1_SKIN)|V600E(IGR37_SKIN)|V600E(IGR39_SKIN)|V600E(K029AX_SKIN)|V600E(KG1C_CENTRAL_NERVOUS_SYSTEM)|V600E(LOXIMVI_SKIN)|V600E(MALME3M_SKIN)|V600E(MELHO_SKIN)|V600E(OUMS23_LARGE_INTESTINE)|V600E(RKO_LARGE_INTESTINE)|V600E(RPMI7951_SKIN)|V600E(RVH421_SKIN)|V600E(SH4_SKIN)|V600E(SIGM5_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE)|V600E(SKHEP1_LIVER)|V600E(SKMEL24_SKIN)|V600E(SKMEL28_SKIN)|V600E(SKMEL5_SKIN)|V600E(SW1417_LARGE_INTESTINE)|V600E(UACC257_SKIN)|V600E(UACC62_SKIN)|V600E(WM793_SKIN)|V600E(WM88_SKIN)|V600E(WM983B_SKIN)	61	"""Mis, T, O"""	"""AKAP9, KIAA1549"""	"""melanoma, colorectal, papillary thyroid, borderline ov, Non small-cell lung cancer (NSCLC), cholangiocarcinoma, pilocytic astrocytoma"""	NA	Cardio-facio-cutaneous syndrome	NA	Cardiofaciocutaneous syndrome		NA	NA		NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA		Colon(40;35 892 2973 5743 27438)	NA	Dom	yes	NA	7	7q34	673	v-raf murine sarcoma viral oncogene homolog B1	yes	E	15808	Substitution - Missense(15790)|Complex - deletion inframe(17)|Insertion - In frame(1)	thyroid(7476)|skin(3822)|large_intestine(3288)|NS(360)|haematopoietic_and_lymphoid_tissue(336)|ovary(211)|lung(58)|eye(57)|central_nervous_system(53)|soft_tissue(30)|biliary_tract(18)|liver(17)|prostate(13)|breast(10)|upper_aerodigestive_tract(9)|endometrium(8)|pancreas(8)|testis(7)|small_intestine(7)|genital_tract(4)|stomach(4)|bone(3)|autonomic_ganglia(2)|oesophagus(2)|urinary_tract(2)|adrenal_gland(2)|pituitary(1)						NA	NA	NA	NA	NA	112	104	107	NA	NA	NA	NA	7	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	140453136	NA	2203	4300	6503	SO:0001583	missense	Familial Cancer Database	CFC, CFCS	ENSG00000157764	HGNC:1097	NM_004333	Approved	uc003vwc.4	NA	A4D1T4|B6HY61|B6HY62|B6HY63|B6HY64|B6HY65|B6HY66|Q13878|Q3MIN6|Q9UDP8|Q9Y6T3	ENST00000288602.6	37	CCDS5863.1	.|.	.|.	.|.	.|.	.|.	.|.	.|.	.|.	.|.	.|.	A|A	24.0|24.0	4.486113|4.486113	0.84854|0.84854	.|.	.|.	ENSG00000157764|ENSG00000157764	ENST00000288602|ENST00000496384	D|.	0.81739|.	-1.53|.	5.65|5.65	5.65|5.65	0.86999|0.86999	Serine-threonine/tyrosine-protein kinase (1);Protein kinase-like domain (1);Protein kinase, catalytic domain (1);|.	0.000000|.	0.85682|.	D|.	0.000000|.	T|.	0.61565|.	0.2357|.	L|L	0.42245|0.42245	1.32|1.32	0.80722|0.80722	D|D	1|1	D|.	0.55385|.	0.971|.	D|.	0.66351|.	0.943|.	T|.	0.58160|.	-0.7685|.	10|.	0.87932|.	D|.	0|.	.|.	15.9326|15.9326	0.79675|0.79675	1.0:0.0:0.0:0.0|1.0:0.0:0.0:0.0	.|.	600|.	P15056|.	BRAF_HUMAN|.	E|R	600|208	ENSP00000288602:V600E|.	ENSP00000288602:V600E|.	V|X	-|-	2|1	0|0	BRAF|BRAF	140099605|140099605	1.000000|1.000000	0.71417|0.71417	1.000000|1.000000	0.80357|0.80357	0.998000|0.998000	0.95712|0.95712	9.197000|9.197000	0.94985|0.94985	2.169000|2.169000	0.68431|0.68431	0.529000|0.529000	0.55759|0.55759	GTG|TGA	BRAF-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000348886.1	105.834741	KEEP		-	109.902417	0.305785	37	84	---	---	---	---	1	0.9995725	12	21	0	110	40	97	0	110	2	1	1	189	363	1	882	40	97	0	110	6	TP
ARC	23237	broad.mit.edu	37	8	143695032	143695032	+	Missense_Mutation	SNP	C	C	T			THCA-TCGA-EL-A3GR-Tumor-SM-2HRLM	THCA-TCGA-EL-A3GR-Normal-SM-2HRLR	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	THCA-TCGA-EL-A3GR-Tumor-SM-2HRLM	THCA-TCGA-EL-A3GR-Normal-SM-2HRLR	g.chr8:143695032C>T	ENST00000356613.2	-	1	1801	c.601G>A	c.(601-603)Gag>Aag	p.E201K	ARC_ENST00000581404.1_5'Flank	NM_015193.3	NP_056008.1	Q7LC44	ARC_HUMAN	activity-regulated cytoskeleton-associated protein	201	Required for binding DNM2 (By similarity).	NA			endocytosis	acrosomal vesicle|cell junction|dendritic spine|endosome|postsynaptic density|postsynaptic membrane				breast(1)|endometrium(1)|haematopoietic_and_lymphoid_tissue(3)|large_intestine(4)|lung(3)|upper_aerodigestive_tract(1)	13	all_cancers(97;3.55e-12)|all_epithelial(106;1.03e-08)|Lung NSC(106;0.000353)|all_lung(105;0.00092)|Medulloblastoma(13;0.00276)|all_neural(13;0.00559)|Ovarian(258;0.0254)|Acute lymphoblastic leukemia(118;0.155)	Acute lymphoblastic leukemia(644;0.0279)				TGCCCGTCCTCGCCGGGGACC	0.726		NA				NA		NA			NA	NA		NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA			NA			NA	NA		NA				0								NA	NA	NA	NA	NA	13	15	14	NA	NA	NA	NA	8	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	143695032	NA	2175	4266	6441	SO:0001583	missense			ENSG00000198576	HGNC:648		Approved	uc003ywn.2	NA	Q9UJW6|Q9Y469	ENST00000356613.2	37	CCDS34950.1	.	.	.	.	.	.	.	.	.	.	C	13.03	2.114641	0.37339	.	.	ENSG00000198576	ENST00000356613	T	0.35605	1.3	4.56	4.56	0.56223	.	0.125935	0.35585	U	0.003117	T	0.20618	0.0496	N	0.19112	0.55	0.30131	N	0.804773	B	0.32071	0.355	B	0.19148	0.024	T	0.11227	-1.0596	10	0.29301	T	0.29	.	12.2406	0.54540	0.0:0.8282:0.1718:0.0	.	201	Q7LC44	ARC_HUMAN	K	201	ENSP00000349022:E201K	ENSP00000349022:E201K	E	-	1	0	ARC	143692034	0.878000	0.30173	0.900000	0.35374	0.141000	0.21300	2.313000	0.43735	2.075000	0.62263	0.462000	0.41574	GAG	ARC-001	KNOWN	NMD_exception|basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000259274.2	38.843632	KEEP		-	39.149382	0.4	14	21	---	---	---	---	1	0.9999954	24	18	0	37	17	24	0	37	2	0	0	0	0	0	0	17	24	0	37	2	TP
ANKRD19P	0	broad.mit.edu	37	9	95599903	95599903	+	RNA	SNP	G	G	A			THCA-TCGA-EL-A3GR-Tumor-SM-2HRLM	THCA-TCGA-EL-A3GR-Normal-SM-2HRLR	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	THCA-TCGA-EL-A3GR-Tumor-SM-2HRLM	THCA-TCGA-EL-A3GR-Normal-SM-2HRLR	g.chr9:95599903G>A	ENST00000473204.1	+	0	1984										NA		NA									NA						CGTCATATTTGAACTTGTCGA	0.552		NA				NA		NA			NA	NA		NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA			NA			NA	NA		NA				0								NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA										NA		ENST00000473204.1	37																																																																																				ANKRD19P-004	KNOWN	basic	processed_transcript	NA	pseudogene	OTTHUMT00000053116.3	52.750146	KEEP		+	53.944217	0.35	21	39	---	---	---	---	1	0.877696	2	7	0	68	25	45	0	68	2	0	0	0	0	0	0	25	45	0	68	2	TP
PSAP	5660	broad.mit.edu	37	10	73577227	73577227	+	Nonsense_Mutation	SNP	C	C	A			THCA-TCGA-EL-A3GR-Tumor-SM-2HRLM	THCA-TCGA-EL-A3GR-Normal-SM-2HRLR	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	THCA-TCGA-EL-A3GR-Tumor-SM-2HRLM	THCA-TCGA-EL-A3GR-Normal-SM-2HRLR	g.chr10:73577227C>A	ENST00000394936.3	-	14	1693	c.1546G>T	c.(1546-1548)Gag>Tag	p.E516*	PSAP_ENST00000394934.1_Nonsense_Mutation_p.E518*			P07602	SAP_HUMAN	prosaposin	516	Saposin A-type 2.	NA			glycosphingolipid metabolic process|lipid transport|platelet activation|platelet degranulation	extracellular space|Golgi apparatus|integral to membrane|lysosomal lumen	enzyme activator activity|lipid binding			endometrium(1)|haematopoietic_and_lymphoid_tissue(1)|kidney(1)|large_intestine(3)|lung(3)|ovary(1)|pancreas(1)|prostate(1)|skin(1)	13						TTGCAATGCTCGACAGCCTGG	0.478		NA				NA		NA			NA	NA		NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA			NA			NA	NA		NA				0								NA	NA	NA	NA	NA	171	160	164	NA	NA	NA	NA	10	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	73577227	NA	2203	4300	6503	SO:0001587	stop_gained			ENSG00000197746	HGNC:9498	NM_002778	Approved	uc001jsm.3	NA	P07292|P15793|P78538|P78541|P78546|P78547|P78558|Q6IBQ6|Q92739|Q92740|Q92741|Q92742	ENST00000394936.3	37	CCDS7311.1	.	.	.	.	.	.	.	.	.	.	C	23.6	4.430984	0.83776	.	.	ENSG00000197746	ENST00000394936;ENST00000373120;ENST00000357471;ENST00000394934;ENST00000394929;ENST00000404083;ENST00000394940	.	.	.	5.02	5.02	0.67125	.	0.334347	0.31976	N	0.006772	.	.	.	.	.	.	0.58432	D	0.999999	.	.	.	.	.	.	.	.	.	.	0.25106	T	0.35	-4.7416	14.008	0.64478	0.0:0.9246:0.0:0.0754	.	.	.	.	X	516;516;519;518;232;522;442	.	ENSP00000350063:E519X	E	-	1	0	PSAP	73247233	0.994000	0.37717	0.915000	0.36163	0.388000	0.30384	4.764000	0.62264	2.492000	0.84095	0.655000	0.94253	GAG	PSAP-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000048553.1	-36.050925	KEEP		-	6.615858	0.023669	4	165	---	---	---	---	1	0.9999999	2	3795	0	178	5	185	0	178	2	0	0	0	0	0	0	5	185	0	178	2	TP
AASDHPPT	60496	broad.mit.edu	37	11	105961348	105961348	+	Silent	SNP	A	A	G			THCA-TCGA-EL-A3GR-Tumor-SM-2HRLM	THCA-TCGA-EL-A3GR-Normal-SM-2HRLR	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	THCA-TCGA-EL-A3GR-Tumor-SM-2HRLM	THCA-TCGA-EL-A3GR-Normal-SM-2HRLR	g.chr11:105961348A>G	ENST00000278618.4	+	3	696	c.474A>G	c.(472-474)gaA>gaG	p.E158E	RP11-677I18.3_ENST00000532422.1_RNA	NM_015423.2	NP_056238.2	Q9NRN7	ADPPT_HUMAN	aminoadipate-semialdehyde dehydrogenase-phosphopantetheinyl transferase	158		NA			macromolecule biosynthetic process|pantothenate metabolic process	cytosol	holo-[acyl-carrier-protein] synthase activity|magnesium ion binding|protein binding			endometrium(3)|kidney(2)|large_intestine(4)|lung(7)|prostate(1)	17		Melanoma(852;0.000878)|Acute lymphoblastic leukemia(157;0.000967)|all_hematologic(158;0.0017)|Breast(348;0.0321)		BRCA - Breast invasive adenocarcinoma(274;5.78e-05)|Epithelial(105;0.00622)|all cancers(92;0.041)		AAGAATGGGAAACAATCAGAA	0.303		NA				NA		NA			NA	NA		NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA			NA			NA	NA		NA				0								NA	NA	NA	NA	NA	103	118	113	NA	NA	NA	NA	11	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	105961348	NA	2201	4297	6498	SO:0001819	synonymous_variant			ENSG00000149313	HGNC:14235	NM_015423	Approved	uc001pjc.1	NA	B2R6D1|Q9C068|Q9P0Q3|Q9UG80|Q9Y389	ENST00000278618.4	37	CCDS31664.1																																																																																			AASDHPPT-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000388734.1	-22.679407	KEEP		+	7.052295	0.02521	3	116	---	---	---	---	1	0.6684807	2	88	0	124	3	130	0	124	2	0	0	0	0	0	0	3	130	0	124	2	TP
PCNXL4	64430	broad.mit.edu	37	14	60581721	60581721	+	Missense_Mutation	SNP	G	G	C			THCA-TCGA-EL-A3GR-Tumor-SM-2HRLM	THCA-TCGA-EL-A3GR-Normal-SM-2HRLR	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	THCA-TCGA-EL-A3GR-Tumor-SM-2HRLM	THCA-TCGA-EL-A3GR-Normal-SM-2HRLR	g.chr14:60581721G>C	ENST00000406854.1	+	4	1453	c.899G>C	c.(898-900)gGa>gCa	p.G300A	PCNXL4_ENST00000317623.4_Missense_Mutation_p.G66A|PCNXL4_ENST00000404681.2_Missense_Mutation_p.G300A|PCNXL4_ENST00000406949.1_Missense_Mutation_p.G66A					pecanex-like 4 (Drosophila)	NA		NA									NA						ATGTCTGCTGGAACAGCTATA	0.308		NA				NA		NA			NA	NA		NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA			NA			NA	NA		NA				0								NA	NA	NA	NA	NA	78	64	68	NA	NA	NA	NA	14	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	60581721	NA	1830	4100	5930	SO:0001583	missense			ENSG00000126773	HGNC:20349	NM_022495	Approved	uc001xer.4	NA		ENST00000406854.1	37		.	.	.	.	.	.	.	.	.	.	G	1.293	-0.607078	0.03717	.	.	ENSG00000126773	ENST00000317623;ENST00000406854;ENST00000406949;ENST00000404681	T;T;T;T	0.22743	1.96;1.97;1.94;1.97	5.08	4.17	0.49024	.	.	.	.	.	T	0.15825	0.0381	L	0.52011	1.625	0.80722	D	1	B;P	0.42409	0.386;0.779	B;B	0.35182	0.052;0.197	T	0.04481	-1.0948	9	0.05721	T	0.95	.	14.2012	0.65705	0.0:0.2853:0.7147:0.0	.	300;66	Q63HM2;B5MC47	CN135_HUMAN;.	A	66;300;66;300	ENSP00000317396:G66A;ENSP00000384801:G300A;ENSP00000385201:G66A;ENSP00000385713:G300A	ENSP00000317396:G66A	G	+	2	0	C14orf135	59651474	1.000000	0.71417	1.000000	0.80357	0.941000	0.58515	4.033000	0.57282	1.227000	0.43598	0.462000	0.41574	GGA	PCNXL4-005	KNOWN	not_organism_supported|basic	protein_coding	NA	protein_coding	OTTHUMT00000317847.1	34.21066	KEEP		+	36.705454	0.25	11	33	---	---	---	---	1	0.999772	15	32	0	35	13	36	0	35	2	0	0	0	0	0	0	13	36	0	35	2	TP
DHX8	1659	broad.mit.edu	37	17	41577392	41577392	+	Silent	SNP	C	C	G			THCA-TCGA-EL-A3GR-Tumor-SM-2HRLM	THCA-TCGA-EL-A3GR-Normal-SM-2HRLR	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	THCA-TCGA-EL-A3GR-Tumor-SM-2HRLM	THCA-TCGA-EL-A3GR-Normal-SM-2HRLR	g.chr17:41577392C>G	ENST00000262415.3	+	11	1539	c.1467C>G	c.(1465-1467)ctC>ctG	p.L489L	DHX8_ENST00000540306.1_Silent_p.L489L	NM_004941.1	NP_004932.1	Q14562	DHX8_HUMAN	DEAH (Asp-Glu-Ala-His) box polypeptide 8	489		NA				catalytic step 2 spliceosome	ATP binding|ATP-dependent RNA helicase activity|protein binding|RNA binding			breast(1)|central_nervous_system(1)|endometrium(3)|kidney(3)|large_intestine(9)|lung(17)|ovary(2)|pancreas(1)|prostate(1)|skin(3)|urinary_tract(1)	42		Breast(137;0.00908)		BRCA - Breast invasive adenocarcinoma(366;0.08)		GGCGGGAACTCAAACAGGCCC	0.532		NA				NA		NA			NA	NA		NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA		NSCLC(56;1548 1661 49258 49987)	NA			NA	NA		NA				0								NA	NA	NA	NA	NA	174	182	179	NA	NA	NA	NA	17	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	41577392	NA	2203	4300	6503	SO:0001819	synonymous_variant				HGNC:2749		Approved	uc002idu.1	NA		ENST00000262415.3	37	CCDS11464.1																																																																																			DHX8-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000453485.1	402.829748	KEEP		+	407.135804	0.374194	116	194	---	---	---	---	1	1	30	33	0	339	118	205	0	339	2	0	0	0	0	0	0	118	205	0	339	2	TP
RP11-156P1.3	0	broad.mit.edu	37	17	45128792	45128792	+	RNA	SNP	G	G	T	rs143713325	by1000genomes	THCA-TCGA-EL-A3GR-Tumor-SM-2HRLM	THCA-TCGA-EL-A3GR-Normal-SM-2HRLR	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	THCA-TCGA-EL-A3GR-Tumor-SM-2HRLM	THCA-TCGA-EL-A3GR-Normal-SM-2HRLR	g.chr17:45128792G>T	ENST00000575173.1	-	0	418				LRRC37A17P_ENST00000570478.1_RNA						NA		NA									NA						AATTCAGGTTGTCAGAATGCA	0.373		NA				NA		NA			NA	NA		NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA			NA			NA	NA		NA				0								NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA										NA		ENST00000575173.1	37																																																																																				RP11-156P1.3-009	KNOWN	basic	lincRNA	NA	processed_transcript	OTTHUMT00000440924.1	-0.410732	KEEP		-	7.538974	0.071429	3	39	---	---	---	---	1	0.3955697	17	29	1	63	3	39	1	63	5	0	0	0	0	0	0	3	39	1	63	2	TP
